A First-of-Its-Kind Multi-Phase Dermal Modulation Platform
DeepLayer is engineered to support the transport of bioactive small molecules beyond the skin surface — into deeper biological environments where they can exert meaningful physiological effects.
Multi
Delivery Phases
Patent-Pending
Technology Status
1 oz
Volume
The Problem
Existing Delivery Methods Fall Short
Traditional delivery routes carry significant limitations — from bioavailability loss to patient compliance barriers. DeepLayer addresses the gap.
Oral Delivery Limitations
- First-pass hepatic metabolism reduces bioavailability
- GI degradation of sensitive bioactives
- Inconsistent absorption due to food interactions
- Delayed onset — systemic distribution required
- Patient compliance challenges with daily dosing
- Formulation complexity for hydrophobic compounds
Injectable Limitations
- Needle aversion and patient compliance barriers
- Sterility requirements increase manufacturing cost
- Administration requires clinical or trained personnel
- Risk of injection-site reactions and complications
- Cold-chain logistics for biologics and peptides
- Regulatory burden for parenteral drug products
DeepLayer bridges this gap — offering a non-invasive, topically applied platform that supports meaningful dermal penetration without the compliance barriers of oral delivery or the clinical requirements of injectable administration.
The Skin Barrier
Understanding the Biological Challenge
The skin is the body's largest organ and most formidable barrier. DeepLayer is engineered to navigate each layer with precision.
Epidermis
Outer Skin Layer
- —Stratum corneum lipid barrier
- —Tightly packed dead keratinocytes
- —Primary barrier to molecular entry
- —Enzymatic degradation risk
Dermis
Connective Tissue Layer
- —Collagen and elastin matrix
- —Rich vascular & lymphatic network
- —Systemic absorption gateway
- —Fibroblast and immune cell activity
Hypodermis
Deep Tissue Target
- —Subcutaneous adipose tissue
- —Deep vascular plexus access
- —Unreachable by conventional topicals
- —DeepLayer target delivery zone
The Platform
DeepLayer Technology Pillars
Four integrated mechanisms work in concert to achieve what conventional topicals cannot.
Barrier Modulation
DeepLayer employs a proprietary combination of penetration-enhancing agents that temporarily and reversibly modulate the lipid architecture of the stratum corneum — creating transient pathways for molecular transport without disrupting barrier integrity long-term.
- ◆ Reversible lipid fluidization
- ◆ Intercellular pathway expansion
- ◆ Barrier recovery post-application
Lipid Navigation
Specialized lipid-compatible carrier molecules guide hydrophilic and hydrophobic actives through the intercellular lipid matrix — the primary route of transdermal molecular transport.
Hydration Dynamics
Controlled hydration of the stratum corneum expands corneocytes and increases aqueous channel permeability — enhancing transport of polar and charged molecules that would otherwise be excluded.
Beyond Surface Topicals
Unlike conventional topicals that remain at or near the skin surface, DeepLayer is formulated to support meaningful dermal penetration — reaching the viable epidermis and upper dermis where vascular uptake and localized biological activity can occur.
Applications
Platform Application Categories
DeepLayer is a versatile delivery platform adaptable across multiple high-value market verticals.
Recovery & Performance
Transdermal delivery of recovery compounds, anti-inflammatory agents, and performance-supporting bioactives for athletic and active populations.
Wellness & Bioactive
Delivery of vitamins, minerals, adaptogens, and wellness compounds for systemic and localized health support applications.
Cosmetic & Aesthetic
Enhanced delivery of cosmetic actives — retinoids, peptides, antioxidants, and growth factors — into the viable epidermis for meaningful aesthetic outcomes.
Emerging Technologies
Platform licensing for novel bioactive compounds, research-stage molecules, and next-generation transdermal delivery applications.
Partnership
Partner With DeepLayer
DeepLayer is available for licensing, co-development, and white-label integration. We partner with manufacturers, formulators, and brands seeking a scientifically differentiated transdermal platform.
Ideal Partner Profiles
Topical Manufacturers
Seeking differentiated delivery technology for existing product lines
Biotech & Pharma
Exploring non-invasive delivery alternatives for pipeline compounds
Wellness Brands
Building science-backed transdermal product categories
Contract Formulators
Adding advanced penetration technology to formulation capabilities
Research Institutions
Investigating transdermal delivery for novel bioactive molecules